{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:00:40Z","timestamp":1792458040701,"version":"4.5.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>This review summarizes current knowledge about the occurrence of hearing and balance disorders after antimalarial drugs treatment. It also examines the clinical applications of antimalarials, their mechanisms behind this ototoxicity and how it can be monitored. It includes studies with larger numbers of patients and those in which auditory function was assessed using audiological tests. Some antimalarials have been repurposed for other conditions like autoimmune disorders, rheumatic diseases, some viral diseases and cancers. While old antimalarial drugs, such as quinoline derivatives, are known to demonstrate ototoxicity, a number of new synthetic antimalarial agents particularly artemisinin derivatives, demonstrate unknown ototoxicity. Adverse audiovestibular effects vary depending on the medication itself, its dose and route of administration, as well as the drug combination, treated disease and individual predispositions of the patient. Dizziness was commonly reported, while vestibular symptoms, hearing loss and tinnitus were observed much less frequently, and most of these symptoms were reversible. As early identification of ototoxic hearing loss is critical to introducing possible alternative treatments with less ototoxic medications, therefore monitoring systems of those drugs ototoxic side effects are much needed.<\/jats:p>","DOI":"10.3389\/fneur.2021.661740","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T05:24:52Z","timestamp":1618896292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["The Ototoxicity of Antimalarial Drugs\u2014A State of the Art Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Magdalena","family":"Jozefowicz-Korczynska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Lucas Grzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5772\/66933","article-title":"Ototoxicity: old and new foes","volume-title":"Advances in Clinical Audiology","author":"Szczepek","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.2174\/1568026617666170130123520","article-title":"An overview of currently available antimalarials","volume":"17","author":"Gorobets","year":"2017","journal-title":"Curr Top Med Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3410\/B3-24","article-title":"Drugs for malaria: something old, something new, something borrowed","volume":"3","author":"Hobbs","year":"2011","journal-title":"F1000 Biol Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar J."},{"key":"B5","volume-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"key":"B6","unstructured":""},{"key":"B7","unstructured":""},{"key":"B8","unstructured":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MAO.0000000000002809","article-title":"Quinine in otology and neurotology: ototoxicity and historic role in therapy","volume":"42","author":"Semedo","year":"2021","journal-title":"Otol Neurotol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.ajem.2020.07.030","article-title":"Acute chloroquine and hydroxychloroquine toxicity: a review for emergency clinicians","volume":"38","author":"Della Porta","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4236\/pp.2020.1110022","article-title":"Wide applications of chloroquine other than antimalarial","volume":"11","author":"Alani","year":"2020","journal-title":"Pharmacol Pharm."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006491.pub4","article-title":"Mefloquine for preventing malaria during travel to endemic areas","author":"Tickell-Painter","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin Drug Investig."},{"key":"B14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5114\/reum.2018.76904","article-title":"Antimalarials\u2014are they effective and safe in rheumatic diseases?","volume":"56","author":"Ha\u0142adyj","year":"2018","journal-title":"Reumatologia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.drudis.2020.09.010","article-title":"Chloroquine against malaria, cancers and viral diseases","volume":"25","author":"Zhou","year":"2020","journal-title":"Drug Discov Today."},{"key":"B16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/joim.13089","article-title":"Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019","volume":"288","author":"Lechien","year":"2020","journal-title":"J Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"585487","DOI":"10.3389\/fphar.2020.585487","article-title":"The potential roles of artemisinin and its derivatives in the treatment of type 2 diabetes mellitus","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B18","first-page":"28","article-title":"Salicylates, nonsteroidal anfi-inflammatory drugs, quinine and heavy metals","volume-title":"Ototoxicity","author":"Prepageran","year":"2004"},{"key":"B19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/20786204.2013.1087437","article-title":"An overview of pharmacotherapy-induced ototoxicity","volume":"55","author":"Schellack","year":"2013","journal-title":"S Afr Fam Pract."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bcpt.12640","article-title":"Concentration-Response relationship of hearing impairment caused by quinine and salicylate: pharmacological similarities but different molecular mechanisms","volume":"120","author":"Alvan","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/s0196-0709(85)80056-9","article-title":"Effects of noise and quinine on the vessels of stria vascularis. An image analysis study","volume":"6","author":"Smith","year":"1985","journal-title":"Am J Otolaryngol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3109\/00016489109138375","article-title":"Ultrastructural changes in the outer hair cells of the guinea pig cochlea after exposure to quinine","volume":"111","author":"Karlsson","year":"1991","journal-title":"Acta Otolaryngol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0304-3940(90)90393-n","article-title":"Quinine causes outer hair cells to change length","volume":"116","author":"Karlsson","year":"1990","journal-title":"Neurosci Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0378-5955(99)00031-3","article-title":"The effect of quinine on outer hair cell shape, compliance and force","volume":"132","author":"Jarboe","year":"1999","journal-title":"Hear Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"108019","DOI":"10.1016\/j.heares.2020.108019","article-title":"Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity","volume":"395","author":"Davis","year":"2020","journal-title":"Hear Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0378-5955(91)90216-v","article-title":"The effects of quinine on the cochlear mechanics in the isolated temporal bone preparation","volume":"53","author":"Karlsson","year":"1991","journal-title":"Hear Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0378-5955(01)00229-5","article-title":"Quinine-induced alterations of electrically evoked otoacoustic emissions and cochlear potentials in guinea pigs","volume":"154","author":"Zheng","year":"2001","journal-title":"Hear Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1055\/s-2002-25041","article-title":"Der Einfluss von Chinin auf aktive Motilit\u00e4t und Feinstruktur isolierter \u00e4usserer Haarzellen der Meerschweinchenkochlea [The effects of quinine on active motile responses and fine structure of isolated outer hair cells from the Guinea pig cochlea]","volume":"81","author":"Dieler","year":"2002","journal-title":"Laryngorhinootologie."},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/019459989010200110","article-title":"Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol","volume":"102","author":"Puel","year":"1990","journal-title":"Head Neck Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3766\/jaaa.22.2.5","article-title":"Ulfendahl. Differential effects of salicylate, quinine, and furosemide on guinea pig inner and outer hair cell function revealed by the input-output relation of the auditory brainstem response","volume":"22","author":"Pienkowski","year":"2011","journal-title":"J Am Acad Audiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1152\/jn.1998.79.5.2503","article-title":"Efects of quinine on the excitability and voltage-dependent currents of isolated spiral ganglion neurons in culture","volume":"79","author":"Lin","year":"1998","journal-title":"J Neurophysiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0378-5955(98)00008-2","article-title":"Salicylate and quinine selectively increase spontaneous firing rates in secondary auditory cortex","volume":"117","author":"Eggermont","year":"1998","journal-title":"Hear Res."},{"key":"B33","first-page":"32","article-title":"Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use?","volume":"58","author":"Dayan","year":"1998","journal-title":"Med Trop."},{"key":"B34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0361-9230(97)00339-0","article-title":"Dose-dependent brainstem neuropathology following repeated arteether administration in rats","volume":"45","author":"Genovese","year":"1998","journal-title":"Brain Res Bull."},{"key":"B35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1672-2930(09)50018-9","article-title":"Ototoxic effects of mefloquine in cochlear organotypic cultures","volume":"4","author":"Ding","year":"2009","journal-title":"J Otol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12640-020-00170-8","article-title":"Some ototoxic drugs destroy cochlear support cells before damaging sensory hair cells","volume":"37","author":"Ding","year":"2020","journal-title":"Neurotox Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1672-2930(11)50001-7","article-title":"Detection of apoptosis by RT-PCR array in mefloquine-induced cochlear damage","volume":"6","author":"Ding","year":"2011","journal-title":"J Otol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e79817","DOI":"10.1371\/journal.pone.0079817","article-title":"Addition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12640-010-9221-z","article-title":"Mefloquine damage vestibular hair cells in organotypic cultures","volume":"20","author":"Yu","year":"2011","journal-title":"Neurotox Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1017\/s0022215110001301","article-title":"Is halofantrine ototoxic? Experimental study on guinea pig cochlea model","volume":"124","author":"Iskander","year":"2010","journal-title":"J Laryngol Otol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/archotol.1991.01870220110020","article-title":"Quinine-induced tinnitus in rats","volume":"117","author":"Jastreboff","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/MAO.0b013e3181de4662","article-title":"Comparison of salicylate- and quinine-induced tinnitus in rats: development, time course, and evaluation of audiologic correlates","volume":"31","author":"Ralli","year":"2010","journal-title":"Otol Neurotol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0196-0709(88)80033-4","article-title":"Whitworth C. Quinine reduces noxious cochlear effects of furosemide and ethacrynic acid","volume":"9","author":"Rybak","year":"1988","journal-title":"Am J Otolaryngol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10162-012-0353-0","article-title":"Quinoline ring derivatives protect against aminoglycoside-induced hair cell death in the zebrafish lateral line","volume":"13","author":"Ou","year":"2012","journal-title":"J Assoc Res Otolaryngol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"15119","DOI":"10.1038\/s41598-018-33520-w","article-title":"Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage","volume":"8","author":"Rocha-Sanchez","year":"2018","journal-title":"Sci Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e22347","DOI":"10.1371\/journal.pone.0022347","article-title":"Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity","volume":"6","author":"Alharazneh","year":"2011","journal-title":"PLoS ONE."},{"key":"B47","doi-asserted-by":"publisher","first-page":"102640","DOI":"10.1016\/j.amjoto.2020.102640","article-title":"Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature","volume":"8","author":"De Luca","year":"2020","journal-title":"Am J Otolaryngol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1055\/s-0040-1714142","article-title":"Chloroquine and COVID-19: should we care about ototoxicity?","volume":"24","author":"Monteiro","year":"2020","journal-title":"Int Arch Otorhinolaryngol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1136\/annrheumdis-2011-201265","article-title":"Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance network","volume":"71","author":"Jourde-Chiche","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/gerona\/glz166","article-title":"The contribution of ototoxic medications to hearing loss among older adults","volume":"75","author":"Joo","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0168780","DOI":"10.1371\/journal.pone.0168780","article-title":"Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: a pooled analysis of 19, 850 individual patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE."},{"key":"B52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fpubh.2020.00252","article-title":"Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19 treatment: a mini-review","volume":"8","author":"Prayuenyong","year":"2020","journal-title":"Front Public Health."},{"key":"B53","first-page":"14","article-title":"Assessment of short term chloroquine-induced ototoxicity in malaria patients","volume":"15","author":"Subramaniam","year":"2015","journal-title":"Global J Med Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1475-2875-7-179","article-title":"Ototoxicity of artemether\/lumefantrine in the treatment of falciparum malaria: a randomized trial","volume":"7","author":"G\u00fcrkov","year":"2008","journal-title":"Malar J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1475-2875-7-127","article-title":"Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up","volume":"7","author":"Adjei","year":"2008","journal-title":"Malar J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1475-2875-7-233","article-title":"Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand","volume":"7","author":"Carrara","year":"2008","journal-title":"Malar J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.trstmh.2003.11.001","article-title":"Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co- artemether","volume":"98","author":"Toovey","year":"2004","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0385-8146(96)00031-4","article-title":"Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection","volume":"24","author":"Tange","year":"1997","journal-title":"Auris Nasus Larynx."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1128\/AAC.06248-11","article-title":"Artemisinin-Naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study","volume":"56","author":"Benjamin","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4269\/ajtmh.2012.11-0192","article-title":"Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria","volume":"86","author":"Carrasquilla","year":"2012","journal-title":"Am J Trop Med Hyg."},{"key":"B61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-10-237","article-title":"Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial","volume":"10","author":"Ndiaye","year":"2011","journal-title":"Malar J."},{"key":"B62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4269\/ajtmh.2006.74.211","article-title":"A case-control auditory evaluation of patients treated with artemether-lumefantrine","volume":"74","author":"Hutagalung","year":"2006","journal-title":"Am J Trop Med Hyg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1191\/0961203304lu528oa","article-title":"Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry","volume":"13","author":"Borba","year":"2004","journal-title":"Lupus."},{"key":"B64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.2000.63.48","article-title":"Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients","volume":"63","author":"Kissinger","year":"2000","journal-title":"Am J Trop Med Hyg."},{"key":"B65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4269\/ajtmh.2000.62.65","article-title":"Case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant plasmodium falciparum malaria","volume":"62","author":"Van Vugt","year":"2000","journal-title":"Am J Trop Med Hyg."},{"key":"B66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4269\/ajtmh.13-0702","article-title":"Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?","volume":"91","author":"Ramos-Mart\u00edn","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijpddr.2014.03.002","article-title":"Idiosyncratic quinoline central nervous system toxicity: historical insights into the chronic neurological sequelae of mefloquine","volume":"4","author":"Nevin","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"B68","doi-asserted-by":"publisher","first-page":"bcr2016218786","DOI":"10.1136\/bcr-2016-218786","article-title":"Accidental hydroxychloroquine overdose resulting in neurotoxic vestibulopathy","volume":"2017","author":"Chansky","year":"2017","journal-title":"BMJ Case Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12688\/wellcomeopenres.10658.2","article-title":"Antimalarial drugs and the prevalence of mental and neurological manifestations: a systematic review and meta-analysis","volume":"2","author":"Bitta","year":"2017","journal-title":"Wellcome Open Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/s0001-706x(01)00210-8","article-title":"Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults","volume":"8","author":"Rendi-Wagner","year":"2002","journal-title":"Acta Trop."},{"key":"B71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tmaid.2012.03.006","article-title":"Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report","volume":"10","author":"Nevin","year":"2012","journal-title":"Travel Med Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7.1015","DOI":"10.1086\/322694","article-title":"Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study","volume":"33","author":"Overbosch","year":"2001","journal-title":"Clin Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-2009-0343","article-title":"Classification of vestibular symptoms: towards an international classification of vestibular disorders","volume":"19","author":"Bisdorff","year":"2009","journal-title":"J Vestib Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40268-016-0167-3","article-title":"Identification of a syndrome class of neuropsychiatric adverse reactions to mefloquine from latent class modeling of FDA Adverse Event Reporting System data","volume":"17","author":"Nevin","year":"2017","journal-title":"Drugs RD."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2310\/7060.2000.00002","article-title":"Neuropsychiatric problems in 2,500 long-term young travelers to the tropics","volume":"7","author":"Potasman","year":"2000","journal-title":"J Travel Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.7205\/milmed.173.12.1194","article-title":"Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004\u20132006","volume":"173","author":"Andersson","year":"2008","journal-title":"Mil Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tmi.12981","article-title":"Proceedings of the 10th European Congress on Tropical Medicine and International Health; 2017 Oct 16\u201320 Antwerp, Belgium","volume":"22","author":"Lula","year":"2017","journal-title":"Trop Med Int Health."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1.135","DOI":"10.1128\/AAC.42.1.135","article-title":"Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug resistant falciparum malaria","volume":"42","author":"Van Vugt","year":"1998","journal-title":"Antimicrob Agents Chemother."},{"key":"B79","first-page":"264","article-title":"Systems effectiveness and patient adherence to dihydroartemisinin piperaquine in northern Ghana","volume-title":"Proceedings of the 10th European Congress on Tropical Medicine and International Health","author":"Odur","year":"2017"},{"key":"B80","unstructured":"Ototoxicity Monitoring2009"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1121\/1.410022","article-title":"Otoacoustic emissions and quinine sulfate","volume":"95","author":"McFadden","year":"1994","journal-title":"J Acoust Soc Am."},{"key":"B82","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12916-015-0366-8","article-title":"Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions\u2013a prospective multicenter cohort study","volume":"13","author":"Schmutzhard","year":"2015","journal-title":"BMC Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/00016488509108928","article-title":"Alterations of auditory evoked potentials during the course of chloroquine treatment","volume":"99","author":"Bernard","year":"1985","journal-title":"Acta Otolaryngol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1682\/JRRD.2013.04.0092","article-title":"Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA) J Rehabil Res Dev","volume":"51","author":"Konrad-Martin","year":"2014"},{"key":"B85","first-page":"161","article-title":"Monitoring vestibular ototoxicity","volume-title":"Ototoxicity","author":"Kisilevsky","year":"2004"},{"key":"B86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/archotol.1990.01870040046011","article-title":"The development of the dizziness handicap inventory","volume":"116","author":"Jacobson","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B87","doi-asserted-by":"publisher","first-page":"E957","DOI":"10.1002\/lary.28873","article-title":"Chloroquine, hydroxychloroquine and hearing loss: a study in systemic lupus erythematosus patients","volume":"131","author":"Polanski","year":"2020","journal-title":"Laryngoscope."},{"key":"B88","doi-asserted-by":"publisher","first-page":"102483","DOI":"10.1016\/j.amjoto.2020.102483","article-title":"Audiological profile of asymptomatic Covid-19 PCR-positive cases","volume":"41","author":"Mustafa","year":"2020","journal-title":"Am J Otolaryngol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14992027.2020.1776406","article-title":"Does coronavirus affect the audio-vestibular system? A rapid systematic review","volume":"59","author":"Almufarrij","year":"2020","journal-title":"Int J Audiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12936-019-2840-9","article-title":"Long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon","volume":"18","author":"Reiterer","year":"2019","journal-title":"Malar J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1475-2875-9-159","article-title":"Murine malaria is associated with significant hearing impairment","volume":"9","author":"Schmutzhard","year":"2010","journal-title":"Malar J."},{"key":"B92","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1365-3156.2011.02801.x","article-title":"Murine cerebral malaria: histopathology and ICAM 1 immunohistochemistry of the inner ear","volume":"16","author":"Schmutzhard","year":"2011","journal-title":"Trop Med Int Health."},{"key":"B93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1475-2875-11-30","article-title":"Apoptosis of the fibrocytes type 1 in the spiral ligament and blood labyrinth barrier disturbance cause hearing impairment in murine cerebral malaria","volume":"11","author":"Schmutzhard","year":"2012","journal-title":"Malar J."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661740\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T05:25:04Z","timestamp":1618896304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661740\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":93,"alternative-id":["10.3389\/fneur.2021.661740"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.661740","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"article-number":"661740"}}